HOME >> BIOLOGY >> NEWS
Small trial shows daclizumab add-on therapy improves MS outcome

rating scale and in a test of hand function. The clinical improvement was unexpected in such a small trial, since a larger number of patients is usually required to show clinical effects. One patient with extremely high inflammation activity responded initially to daclizumab but, as disease activity returned, was given higher doses of the antibody and was excluded from final analysis.

"There is great interest now in new approaches and new therapies for a disorder about which we know too little and have only moderately effective therapies," said Dr. Martin. "The combined therapy was well tolerated by all patients, with side effects that were either mild or clearly not caused by daclizumab." He said the therapy limits the activity of T-cells that attack the myelin coating around the nerves, without shutting down the entire immune system.

"While these results are preliminary, this discovery offers hope for thousands of patients with certain forms of MS. Findings like this are helping us to better understand how this disease affects the immune system, which offers hope for all MS patients," said Story C. Landis, Ph.D., NINDS director.

Further studies are needed to confirm the extent of the clinical benefit of daclizumab on typical MS patients and determine whether daclizumab is effective as a stand-alone therapy.

The study was a collaboration between the NINDS and its sister agency, the National Cancer Institute (NCI). Thomas Waldmann, M.D., chief of the metabolism branch for NCI's Center for Cancer Research, developed the antibody used in the trial.

Daclizumab (trade name Zenapax) received FDA approval in 1997 for use in kidney transplantation.


'"/>

Contact: Paul Girolami
301-496-5751
NIH/National Institute of Neurological Disorders and Stroke
24-May-2004


Page: 1 2

Related biology news :

1. Small, Smac-like molecule encourages death of cancer cells
2. Small animal imaging gives cancer clues
3. Small RNA surmounts large cancer problem
4. Small, cold, & hungry: Ultra-small microbes from 120,000-year-old glacier ice sample
5. Small gene changes in some leukemia patients may explain varying responses to chemotherapy
6. Small amounts of alcohol or anesthetics may damage the developing brain
7. Smallpox in 50-year-old tissues detected by integrated diagnostics approach
8. Small-molecule inhibitors of anthrax lethal factor identified
9. Smallpox in Europe selected for genetic mutation that confers resistance to HIV infection
10. Small-molecule inhibitors of botulinum neurotoxin identified
11. Smallest whirlpools can pack stunningly strong force

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/12/2019)... ... November 12, 2019 , ... Atlantic Ultraviolet Corporation ... today that distributors voted their patented automatic and manual wipers the #1 best ... The most frequent maintenance task required of an ultraviolet water purifier is quartz ...
(Date:11/9/2019)... ... November 08, 2019 , ... ... to form the leading provider of specialized histology, pathology, biomarker development, and ... was recently created by the mergers of Histo-Scientific Research Laboratories (HSRL), Vet ...
(Date:11/6/2019)... ... November 06, 2019 , ... In October, Massachusetts stem ... to patients about a poorly disclosed deficiency in stem cell treatments. Throughout ... of the treating stem cells. This problem affects all patients receiving stem ...
Breaking Biology News(10 mins):
(Date:11/5/2019)... ... 2019 , ... Ole, a German Shepherd, was demonstrating signs of osteoarthritis in April 2019. ... energy level and his willingness to play were normal, it was clear that he was ... VCA Emergency Animal Hospital and Referral Center in San Diego, California. Dr. Mullen ...
(Date:10/30/2019)... CITY, S.D. (PRWEB) , ... October 30, 2019 , ... ... team of researchers and students at South Dakota School of Mines & Technology ... cancer cells while leaving healthy cells alive. , If successful, the technique would ...
(Date:10/29/2019)... , ... October 29, 2019 , ... ... of the skin*. Using Silios CMS-C multispectral imagers , researchers identified people ... can replace identification based on retinal imaging, face recognition, fingerprints and vasculature. ...
(Date:10/22/2019)... ANGELES (PRWEB) , ... October 22, 2019 , ... ... provider, today announced integration of the Alertus Mass Notification System into its digital ... infrastructure to the Enplug platform, making it possible for users to leverage their ...
Breaking Biology Technology:
Cached News: